References
- Yaksh, T. L. : Tolerance: Factors involved in changes in the dose-effect relationship with chronic drug exposure. In: Towards a New Pharmacotherapy of Pain (Basbaum, A. I., Bessan, J.-M., Eds.), Wiley, Chichester, UK, p. 157 (1991)
- Houde, R. W., Wallenstein, S. L. and Beaver, W. T. : Evaluation of analgesics in patients with cancer pain. In: International Encyclopedia of Pharmacology and Therapeutics (Lasagna, L., Ed.), Section 6, 1. Clinical Pharmacology. Pergamon, Oxford. p. 59 (1996)
- Foley, K. M. : Clinical tolerance to opioids. In: Towards a New Pharmacotherapy of Pain (Basbaum, A. I.,Bessan, J.-M., Eds.), Wiley, Chichester; UK. p. 181 (1991)
- Portenoy, R. K. : Tolerance to opioid analgesics: Clinical aspects. In: Cancer Surveys, Vol. 21, Palliative Medicine: Problem Areas in Pain and Symptom Management. Imperial Cancer Research Fund. p. 49 (1994)
- Ling, G. S. F., Simantov, R. and Pasternak, G. W. : Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sci. 45, 1627 (1989) https://doi.org/10.1016/0024-3205(89)90272-5
- McGilliar, K. L. and Takemori, A. E. : Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment. J. Pharmacol. Exp. Ther. 207, 884 (1978)
- Suzuki, T., Narita, M., Takahashi, Y, Misawa, M. and Nagase, H. : Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur. J. Pharmacol. 213, 91 (1992) https://doi.org/10.1016/0014-2999(92)90237-X
- Schmidt, W. K., Tam, S. W. and Shotzberger; G. S. : Nalbuphine. Drug Alcohol Depend. 14, 339 (1985) https://doi.org/10.1016/0376-8716(85)90066-3
-
Pick, C. G., Paul, D. and Pasternak, G. W. : Nalbuphine, a mixed
$\kappa$ 1 and$\kappa$ 3 analgesic in mice. J. Pharmacol. Exp. Ther. 262, 1044 (1992) - De Souza, E. B., Schmidt, W. K. and Kuhar, M. J. : Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. J. Pharmacol. Exp. Ther. 244, 391 (1988)
-
Walker, E. A. and Young, A. M. : Discriminative-stimulus effects of the low efficacy
$\mu$ agonist nalbuphine.J. Pharmacol. Exp. Ther. 267, 322 (1993) - Chen, J. C., Smith, E. R. and Cahill, M. : The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci. 52, 389 (1992)
- Bailey, P. L., Clark, N. J. and Pace, N. L. : Antagonism of postoperative opioid-induced respiratory depression: nalbuphine versus naloxone. Anesth. Analg. 66, 1109 (1987)
- Davies, G. G. and From, R. A. : Blinded study using nalbuphine for prevention of pruritus induced by epidural fentanyl. Anesthesiology. 69, 763 (1988) https://doi.org/10.1097/00000542-198809010-00763
- Baxter, A. D., Samson, B. and Penning, J. P. : Prevention of epidural morphine-induced respiratory depression with intravenous nalbuphine infusion in post-thoractomy patients. Can. J. Anaesth., 36, 503 (1989)
- Cohen, S. E., Ratner, E. F. and Kreitzman, T. R. : Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anaesth. Analg. 75, 747 (1992)
- Mills, C. A., Flacke, J. W. and Flacke, W. E. : Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine. Can. J. Anaesth. 37, 238 (1990)
- Mushlin, B. E. and Cochin, J, : Tolerance to morphine in the rat: its prevention by naloxone. Life Sci. 18, 797 (1976)
- Yano, I. and Takemori, A. E. : Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine. Res. Commun. Chem. Pathol. Pharmacol. 16, 721 (1977)
- Kayer, V. and Guilbaud, G. : The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats. Brain Res. 267, 131 (1983) https://doi.org/10.1016/0006-8993(83)91046-6
- Rattan, A. K. and Sribanditmongkol, P. : Effect on morphineinduced catalepsy, lethality, and analgesia by a benzodiazepine receptor agonist midazolam in the rat. Pharmacol. Biochem. Behav. 48, 357 (1994) https://doi.org/10.1016/0091-3057(94)90538-X
- Carlezon, W. A., Kosten, T. A. and Nestler, E. J, : Behavioral interactions caused by combined administration of morphine and MK-801 in rats. Psychopharmacology. 151, 261 (2000) https://doi.org/10.1007/s002130000462
-
Yamamoto, T., Ohno, M. and Ueki, S.: A selective
$\kappa$ -opioid agonist, U-50, 488H, blocks the development of tolerance to morphine analgesia in rats. Eur. J. Pharmacol. 156, 173 (1988) https://doi.org/10.1016/0014-2999(88)90162-8 - Tao, P. L., Hwang, C. L. and Chen, C. Y. : U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Eur. J. Pharmacol. 256, 281 (1994) https://doi.org/10.1016/0014-2999(94)90553-3
- Takemori, A. E., Loh, H. H. and Lee, N. M. : Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur. J. Pharmacol. 221, 223 (1992) https://doi.org/10.1016/0014-2999(92)90705-9
- Green, P. G. and Lee, N. M. : Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration. Eur. J. Pharmacol. 145, 267 (1988)
-
DeLander, G. E., Portoghese, P. S. and Takemori, A. E. : Role of spinal
$\mu$ opioid receptors in the development of morphine tolerance and dependence. J. Pharmacol. Exp. Ther. 231, 91 (1984) -
Yu. V. C. and Sadee, W. : Efficacy and tolerance of narcotic analgesic at the
$\mu$ opioid receptor in differential human neuroblastoma cells. J. Pharmacol. Exp. Ther. 245, 350 (1988) -
Adams, R. E. and Wooten, G. F. : Is morphine dependence mediated exclusively by the
$\mu$ receptor? Neurochem. Res. 18, 1041 (1993) - Pande, A. C., Pyke, R. E., Greiner, M., Cooper, S.A., Benjamin, R. and Pierce, M. W. : Analgesic efficacy of the kappa-receptor agonist, enadoline, in dental surgery pain. Clin. Neuropharmacol: 19, 92 (1996)
- Von Voigtlander, P. F. and Lewis, R A. : U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists. Prog. Neuropsychopharmacol Biol. Psychiatry. 6, 467 (1982)
- Millan, M. J., Czlonkowski, A., Lipkowski, A. and Herz, A.: Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. J. Pharmacol. Exp. Ther. 251, 342 (1989)
- Takemori, A. E., Ho, B. Y., Naeseth, J. S. and Portoghese, P. S. : Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246, 255 (1988)
- Herman, B. H. and Goldstein, A. : Antinociception and paralysis induced by intrathecal dynorphin A. J. PharmacoL Exp. Ther. 232, 27 (1985)
- Gogas, K. R., Levine, J. D. and Basbaum, A. I. : Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalinevoked C-fos expression. J. Pharmacol. Exp. Ther. 276, 80 (1996)
- Stevens, C. W. and Yaksh, T. L. : Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.J. Pharmacol. Exp. Ther. 238, 833 (1986)
- Leighton, G. E., Rodriguez, R. E., Hill, R. G. and Hughes, J. : kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br. J. Pharmacol. 93, 553 (1988)
- Tiseo, P. J., Geller, E. B. and Adler, M. W. : Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat. J. Pharmacol. Exp. Ther. 246, 449 (1988)
- Tulunay, F. C., Jen, M. F., Chang, J. K., Loh, H. H. and Lee, N. M. : Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. J. Pharmacol. Exp. Ther. 219, 296 (1983)
- Friedman, H. J., Jen, M. F., Chang, J, K., Lee, N. M. and Loh, H. H. : Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse. Eur. J. Pharmacol. 69, 357 (1981)
- Ramarao, P., Jablonski, J, H. I., Rehder, K. R. and Bhargava, H. N. : Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats. Eur. J. Pharmacol. 156, 239 (1988) https://doi.org/10.1016/0014-2999(88)90327-5
- Bhargava, H. N. : Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol. Rev. 46, 293 (1994)
- Rothman, R. B. : A review of the role of anti-opioidpeptides in morphine tolerance and dependence. Synapse. 12, 129 (1992) https://doi.org/10.1002/syn.890120206
- Schmauss,C. and Herz, A. : Intrathecally administered dynorphin(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats. Eur. J. Pharmacol. 135, 429 (1987) https://doi.org/10.1016/0014-2999(87)90695-9
- Hooke, L. P., He, L. and Lee, N. M. : Dynorphin A modulates acute and chronic opioid effects. J. Pharmacol. Exp. Then 273, 292 (1995)
- Takahashi, M., Senda, T. and Kaneto, H. : Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine. Eur. J. Pharmacol. 200, 293 (1991) https://doi.org/10.1016/0014-2999(91)90585-E
- Cowan, A., Zhu, X. Z., Mosberg, H. I., Omnaas, J. R. and Porreca, E : Direct dependence studies in rats with agents selective for different types of opioid receptor. J. Pharmacol. Exp. Ther. 246, 950 (1988)
- Suzuki, T., Hayashi, Y. and Misawa, M. : The role of mu1 receptor in physical dependence on morphine using the mu receptor deficient CXBK mouse. Life Sci. 50, 849 (1992) https://doi.org/10.1016/0024-3205(92)90203-2
- Fukagawa, Y., Katz, J.L. and Suzuki, T. : Effects of a selective kappa-opioid, U50488H, on morphine dependence in rats. Eur. J. Pharmacol. 170, 47 (1989) https://doi.org/10.1016/0014-2999(89)90132-5
- Penning, J., Samson, B. and Baxter, A.D. : Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine. Can. J. Anaesth. 35, 599 (1988) https://doi.org/10.1007/BF03020347